Recalled Product Destruction Incinerators

A recalled product incinerator is a dual-chamber unit used to destroy medicinal product withdrawn from the supply chain — a defective batch, a quality deviation, a falsified line or a discontinued presentation — on the site holding the returned stock. The regulatory driver is not the waste rules but Good Manufacturing and Distribution Practice: recalled product has to be securely segregated and destroyed under a documented procedure that reconciles what came back against what went out. That reconciliation is what makes on-site destruction attractive. A recall stays open until the numbers close, and every transfer to a third party puts a gap between the quantity you counted and the destruction you certified. Charging the stock yourself, with a nominated witness present and a run log behind it, closes the loop in one step rather than three. The combustion condition is the standard one: 850–1,200°C in the primary chamber with two-second secondary retention above 850°C, rising to 1,100°C where the charge carries more than 1% halogenated organic content. For recall purposes the important property is irreversibility — after the run there is no dose form, no legible pack, no reconstructable label and no artwork that could re-enter a market. Falsified product deserves its own mention. Counterfeit medicines have a resale value that expired stock does not, and the entire point of destroying them is that they never reach a buyer. A transfer to a contractor is exactly the movement that risk assessment is trying to eliminate; a charge door on your own site is not.

6,000 kg of returned stock against the LBI-250's 250 kg/h = about 24 hours of running, or three witnessed eight-hour shifts inside one week, leaving 180–300 kg of ash and no transfer of recalled product to a third party. Recall volumes arrive in a spike, not a flow. Size on the worst recall you have run rather than on the monthly average, because the average never sets the deadline.

Yes, provided the environmental permit names the medicinal waste codes and the destruction is carried out under a documented GMP procedure with records retained. Doing it on site is usually the stronger position: the reconciliation and the destruction happen in the same place, under the same signatures, rather than being separated by a consignment note.

For controlled drugs it is a legal requirement with a specified class of witness. For ordinary recalled product it is a GMP expectation rather than a statutory one, but nominating a witness — usually the QP or responsible person who signed the recall — is what turns a run log into evidence. The charge door is interlocked and the run is time-stamped, so witnessing is straightforward.

It is charged with the product and destroyed with it. Cartons, leaflets, labels, tamper-evident features and foil all leave as ash or inert metal. That matters most for falsified lines and for obsolete artwork, where an intact printed component has more value to a counterfeiter than the dose form does.

Once it is released from any investigation hold, yes — and on-site destruction is the point. Falsified product has a resale market, so every movement is a risk. What you must not do is destroy material the MHRA or an enforcement body still needs as evidence, so confirm the position before it reaches a manifest.

By burn rate. An LBI-250 clears 250 kg an hour continuously, so a six-tonne return is about 24 hours of running — three witnessed shifts inside a week. The constraint in practice is usually how fast returned stock is reconciled into quarantine, not how fast the unit takes it.

On the worst recall you have run, not the monthly average. Recall volume arrives as a spike against a deadline, and a unit sized on routine write-off will be the reason the reconciliation stays open. The LBI-250 covers most single-presentation recalls; the LBI-375 and LBI-500 suit manufacturers and national wholesalers.